Factors moderating the relative effectiveness of varenicline and nicotine replacement therapy in clients using smoking cessation services

Publisher： John Wiley & Sons Inc

E-ISSN： 1360-0443|113|2|313-324

ISSN： 0965-2140

Source： ADDICTION, Vol.113, Iss.2, 2018-02, pp. : 313-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An exploratory short‐term double‐blind randomized trial of varenicline versus nicotine patch for smoking cessation in women

By  

ADDICTION, Vol. 110, Iss. 6, 2015-06 ,pp. : 1027-1034

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development and testing of new nicotine replacement treatments: from ‘nicotine replacement’ to ‘smoking replacement’

By  

ADDICTION, Vol. 110, Iss. S2, 2015-07 ,pp. : 19-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of stop‐smoking medications in the United States before and after the introduction of varenicline

By  

ADDICTION, Vol. 110, Iss. 2, 2015-02 ,pp. : 346-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rewarding smoking cessation in pregnancy‐will women cheat to gain incentives?

By  

ADDICTION, Vol. 110, Iss. 4, 2015-04 ,pp. : 689-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distress, race/ethnicity and smoking cessation in treatment‐seekers: implications for disparity elimination

By  

ADDICTION, Vol. 110, Iss. 9, 2015-09 ,pp. : 1495-1504

John Wiley & Sons Inc

Access to resources Recommend Favorite